These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3325284)

  • 41. Antibodies to ring-infected erythrocyte surface antigen (Pf155/RESA) protect against P. falciparum parasitemia in highly exposed multigravidas women in Malawi.
    Astagneau P; Steketee RW; Wirima JJ; Khoromana CO; Millet P
    Acta Trop; 1994 Sep; 57(4):317-25. PubMed ID: 7528968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular cloning of Plasmodium falciparum blood stage antigens and application of the recombinant proteins in serodiagnosis.
    Liu KY; Saul A
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):402-5. PubMed ID: 1488692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of domains of the phosphoriboprotein P0 of Plasmodium falciparum.
    Chatterjee S; Singh S; Sohoni R; Kattige V; Deshpande C; Chiplunkar S; Kumar N; Sharma S
    Mol Biochem Parasitol; 2000 Apr; 107(2):143-54. PubMed ID: 10779592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children.
    Del Giudice G; Engers HD; Tougne C; Biro SS; Weiss N; Verdini AS; Pessi A; Degremont AA; Freyvogel TA; Lambert PH
    Am J Trop Med Hyg; 1987 Mar; 36(2):203-12. PubMed ID: 2435181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification of Histidine-Rich Protein 3 of Plasmodium falciparum.
    Palani B
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):87-90. PubMed ID: 29634395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of antibodies to soluble Plasmodium falciparum antigen (Pf70) and protection against malaria in a human population living under intense transmission in Kinshasa, Zaire.
    Tshefu K; James MA
    Trop Med Parasitol; 1995 Jun; 46(2):72-6. PubMed ID: 8525288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen.
    Schreiber N; Brattig N; Evans J; Tsiri Agbenyega ; Horstmann RD; May J; Klinkert MQ
    Microbes Infect; 2006 Apr; 8(5):1269-76. PubMed ID: 16679041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens.
    Ondigo BN; Park GS; Gose SO; Ho BM; Ochola LA; Ayodo GO; Ofulla AV; John CC
    Malar J; 2012 Dec; 11():427. PubMed ID: 23259607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous use of Plasmodium falciparum crude antigen and red blood cell control antigen in the enzyme-linked immunosorbent assay for malaria.
    Demedts P; Vermeulen-Van Overmeir C; Wery M
    Am J Trop Med Hyg; 1987 Mar; 36(2):257-63. PubMed ID: 3548452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.
    Ståhl S; Sjölander A; Nygren PA; Berzins K; Perlmann P; Uhlén M
    J Immunol Methods; 1989 Nov; 124(1):43-52. PubMed ID: 2681427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens.
    Fouda GG; Leke RF; Long C; Druilhe P; Zhou A; Taylor DW; Johnson AH
    Clin Vaccine Immunol; 2006 Dec; 13(12):1307-13. PubMed ID: 17035513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
    Lougovskoi AA; Okoyeh NJ; Chauhan VS
    Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.